• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素受体概念及其与糖尿病治疗的关系。

The insulin receptor concept and its relation to the treatment of diabetes.

作者信息

Ward G M

出版信息

Drugs. 1987 Feb;33(2):156-70. doi: 10.2165/00003495-198733020-00004.

DOI:10.2165/00003495-198733020-00004
PMID:3552593
Abstract

The initial step in insulin action is binding to specific receptors. Two covalent receptor modifications possibly involved in producing pharmacodynamic effects as a result of insulin receptor binding are autophosphorylation and disulphide insulin binding. Insulin receptor numbers are 'down regulated' by insulin, but this effect may be minimised by pulsatile insulin secretion. Insulin receptor affinity is modulated rapidly by fasting, exercise and dietary composition. In non-insulin-dependent diabetes coupling of receptor binding to bioeffects is impaired. Binding is also reduced in those subjects with hyperinsulinaemia and non-insulin-dependent diabetes. Insulin-dependent diabetics have reduced insulin sensitivity, which is only partially reversed by conventional insulin therapy. 'Post-binding defects' in some diabetics could be related to defective covalent receptor modifications resulting from genetic receptor defects. High carbohydrate diets improve diabetes control through effects on the binding and coupling defects. In addition to stimulating insulin secretion, oral hypoglycaemics stimulate post-binding insulin action in vivo and in vitro. Insulin therapy in diabetes also tends to reverse post-binding defects. Pulsatile insulin delivery is more effective in lowering blood sugar than continuous administration, and produces less 'down regulation' of receptors. Combined insulin and sulphonylurea drugs reduce insulin requirements only in insulin-dependent diabetics with some endogenous insulin secretion, whereas metformin reduces insulin requirement in C-peptide negative insulin-dependent diabetes mellitus.

摘要

胰岛素作用的起始步骤是与特定受体结合。胰岛素与受体结合后可能产生药效学效应的两种共价受体修饰是自身磷酸化和二硫键胰岛素结合。胰岛素可使胰岛素受体数量“下调”,但脉冲式胰岛素分泌可使这种效应降至最低。禁食、运动和饮食组成可迅速调节胰岛素受体亲和力。在非胰岛素依赖型糖尿病中,受体结合与生物效应之间的偶联受损。高胰岛素血症和非胰岛素依赖型糖尿病患者的胰岛素结合也减少。胰岛素依赖型糖尿病患者的胰岛素敏感性降低,传统胰岛素治疗只能部分逆转这种情况。一些糖尿病患者的“结合后缺陷”可能与遗传受体缺陷导致的共价受体修饰缺陷有关。高碳水化合物饮食通过对结合和偶联缺陷的影响来改善糖尿病控制。除了刺激胰岛素分泌外,口服降糖药在体内和体外均可刺激结合后的胰岛素作用。糖尿病患者的胰岛素治疗也往往会逆转结合后缺陷。脉冲式胰岛素给药在降低血糖方面比持续给药更有效,并且对受体的“下调”作用更小。胰岛素与磺脲类药物联合使用仅在有一定内源性胰岛素分泌的胰岛素依赖型糖尿病患者中可减少胰岛素需求,而二甲双胍可降低C肽阴性胰岛素依赖型糖尿病患者的胰岛素需求。

相似文献

1
The insulin receptor concept and its relation to the treatment of diabetes.胰岛素受体概念及其与糖尿病治疗的关系。
Drugs. 1987 Feb;33(2):156-70. doi: 10.2165/00003495-198733020-00004.
2
Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.二甲双胍治疗对正常体重受试者、肥胖非糖尿病受试者、1型和2型糖尿病患者红细胞胰岛素结合的影响。
Diabete Metab. 1986 Aug;12(4):219-24.
3
Abnormal dietary regulation of erythrocyte insulin receptor affinity in non-insulin-dependent diabetes mellitus.
Clin Endocrinol (Oxf). 1984 Jun;20(6):671-81. doi: 10.1111/j.1365-2265.1984.tb00117.x.
4
Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.非胰岛素依赖型(II型)和胰岛素依赖型(I型)糖尿病中的胰岛素抵抗。
Adv Exp Med Biol. 1985;189:176-205.
5
Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.二甲双胍的作用机制:体外和体内的胰岛素受体及受体后效应
J Clin Endocrinol Metab. 1986 Oct;63(4):898-905. doi: 10.1210/jcem-63-4-898.
6
Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.人类骨骼肌中的胰岛素受体功能与糖原合酶活性。生理学与病理生理学。
Dan Med Bull. 1994 Apr;41(2):179-92.
7
The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients.人胰岛素类似物赖脯胰岛素可改善强化治疗的胰岛素依赖型糖尿病患者循环单核细胞上的胰岛素结合。
J Clin Endocrinol Metab. 1996 Jun;81(6):2319-27. doi: 10.1210/jcem.81.6.8964871.
8
Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者运动后胰岛素受体增加。
N Engl J Med. 1980 Apr 17;302(16):886-92. doi: 10.1056/NEJM198004173021603.
9
[Oral antidiabetic agents: recent aspects].[口服抗糖尿病药物:近期进展]
Schweiz Med Wochenschr. 1983 Apr 30;113(17):645-50.
10
Regulation of the number of insulin receptors in human fat cells.
Acta Endocrinol Suppl (Copenh). 1980;239:19-22.

引用本文的文献

1
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.胰腺内分泌和外分泌信号传导以及生理和病理状态下的相互作用。
Signal Transduct Target Ther. 2025 Feb 14;10(1):39. doi: 10.1038/s41392-024-02098-3.
2
VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway.VEGFB 通过 PI3K/AKT 信号通路改善非酒精性脂肪性肝病的胰岛素抵抗。
J Transl Med. 2024 Oct 28;22(1):976. doi: 10.1186/s12967-024-05621-w.
3
Phase transitions in pancreatic islet cellular networks and implications for type-1 diabetes.

本文引用的文献

1
Comparison of plasma insulin levels following administration of tolbutamide and glucose.服用甲苯磺丁脲和葡萄糖后血浆胰岛素水平的比较。
Diabetes. 1960 Sep-Oct;9:356-62. doi: 10.2337/diab.9.5.356.
2
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.受体及受体后缺陷促成了非胰岛素依赖型糖尿病中的胰岛素抵抗。
J Clin Invest. 1981 Oct;68(4):957-69. doi: 10.1172/jci110350.
3
Effects of tolbutamide on insulin binding to isolated fat cells of the rat.甲苯磺丁脲对胰岛素与大鼠分离脂肪细胞结合的影响。
胰岛细胞网络中的相变及其对1型糖尿病的影响。
Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jan;89(1):012719. doi: 10.1103/PhysRevE.89.012719. Epub 2014 Jan 27.
4
Investigating the role of islet cytoarchitecture in its oscillation using a new beta-cell cluster model.使用一种新的β细胞簇模型研究胰岛细胞结构在其振荡中的作用。
PLoS One. 2007 Oct 3;2(10):e983. doi: 10.1371/journal.pone.0000983.
5
Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.胰岛素和IGF-1受体细胞质结构域的差异信号传导潜力。
EMBO J. 1989 May;8(5):1369-75. doi: 10.1002/j.1460-2075.1989.tb03517.x.
Biochem Pharmacol. 1982 Apr 1;31(7):1227-31. doi: 10.1016/0006-2952(82)90008-9.
4
Validation of a practical in vivo insulin dose-response curve in man.人体实际体内胰岛素剂量-反应曲线的验证。
Metabolism. 1982 Apr;31(4):354-61. doi: 10.1016/0026-0495(82)90110-x.
5
Circadian profiles of insulin receptors in insulin-dependent diabetics in usual and poor metabolic control.胰岛素依赖型糖尿病患者在代谢控制正常和较差情况下胰岛素受体的昼夜变化情况。
Am J Physiol. 1982 Feb;242(2):E127-36. doi: 10.1152/ajpendo.1982.242.2.E127.
6
Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts.极端胰岛素抵抗患者的细胞培养研究。I. 培养成纤维细胞的受体缺陷。
J Clin Endocrinol Metab. 1982 Feb;54(2):261-8. doi: 10.1210/jcem-54-2-261.
7
The effect of sulfhydryl active agents on insulin binding to the erythrocyte insulin receptor.
J Recept Res. 1981;2(1):87-95. doi: 10.3109/10799898109038799.
8
Carbohydrate intake affects insulin binding to human erythrocytes in normal weight subjects but not in subjects with family obesity.碳水化合物摄入量会影响正常体重受试者体内胰岛素与人类红细胞的结合,但对有家族性肥胖的受试者则无此影响。
Metabolism. 1981 Sep;30(9):900-7. doi: 10.1016/0026-0495(81)90069-x.
9
Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes.双胍类药物治疗可增加人体红细胞上胰岛素受体位点的数量。
N Engl J Med. 1981 Sep 3;305(10):563-6. doi: 10.1056/NEJM198109033051007.
10
In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.一种磺脲类药物对脂肪细胞胰岛素作用的体外效应。增强胰岛素刺激的己糖转运。
J Clin Invest. 1981 Jul;68(1):85-90. doi: 10.1172/jci110257.